
Francesco Iannuzzella, European of Italian nationality, Nephrologist, @ISNeducation, @NephJC, "Labor omnia vincit improbus"
Joined April 2013
- Tweets13.1K
- Following2K
- Followers2.1K
- Likes11.9K
Fra Ian 🇪🇺 retweeted
Ten tips for the diagnosis and management of nephrotic syndrome ca. 2026 from @CKJsocial
#Nephpearls
👉🏼 pubmed.ncbi.nlm.nih.gov/4270…
Fra Ian 🇪🇺 retweeted
Nueva revisión de hiperkalemia aguda (BMJ 2026). Lo que cambió, y que probablemente sigas haciendo:
🔴 Dextrosa al 10%, no al 50%. La glucosada hipertónica puede EMPEORAR la hiperkalemia.
🔴 Insulina 5 U (o 0.1 U/kg, máximo 10 U). Misma caída de potasio que con 10 U, con casi la mitad de hipoglucemias (OR 0.55).
🔴 1 g de gluconato de calcio no sirve. 97% necesitó tres dosis de 1 g y una sola dosis no funcionó en NINGUNO. Dosis: 1-3 g.
🔴 El calcio no "estabiliza la membrana". Restaura la conducción por canales de calcio. Traducción práctica: sirve cuando hay QRS ancho, no en la onda T picuda aislada.
🔴 Bicarbonato: no se recomienda de rutina.
🔴 La onda T picuda aparece en menos del 25% de los pacientes con K de 5.5-7.0. Un ECG normal NO descarta hiperkalemia.
🔴 Reevalúa el potasio a los 60 min y otra vez a las 2-4 horas. El rebote es frecuente
El tema ya está re-escrito y actualizado en Memodi y Accio. Completo en el canal (t.me/memodiapparticulos).
Fra Ian 🇪🇺 retweeted
Phase 3 proteinuria and eGFR data for available and emerging IgA Nephropathy #IgAN therapeutics (as of August 3, 2026)
#Nephpearls #GlomConHawaii 🌊
👉 pubmed.ncbi.nlm.nih.gov/4189… – at Kaanapali, HI
Fra Ian 🇪🇺 retweeted
Lupus Nephritis: Management from @hjanders_hans
#Nephpearls #GlomConHawaii 🌊
👉 pubmed.ncbi.nlm.nih.gov/3931… – at Kaanapali, HI
Fra Ian 🇪🇺 retweeted
Presented during the Late-Breaking Clinical Trials Session at #GlomConHawaii 🌺 @GlomCon
Two-year VISIONARY results: Sibeprenlimab reduced proteinuria and preserved eGFR in IgA nephropathy, with consistent benefit across subgroups and a favorable safety profile.
Fra Ian 🇪🇺 retweeted
Mandatory weekend reading for nephrologists:
Disease modification in lupus nephritis
nature.com/articles/s41581-0…
By an SLE all-star ensemble:
@AKronbichler @Lupusreference @smirioglu @LuvacsL @AnnetteBruchfe1 @StefanieSteige6 @sarah_m_moran @OhioStateNeph @KateIsabelle24
Our #IWG @ERAkidney work on disease modification in lupus nephritis has just been published in #NRN
nature.com/articles/s41581-0…
@IoannisParodis @Lupusreference @smirioglu @LuvacsL @AnnetteBruchfe1 @StefanieSteige6 @sarah_m_moran @OhioStateNeph @KateIsabelle24 et al.
Fra Ian 🇪🇺 retweeted
🔥Just published 🔥@PharmacoJournal
with many 🌟s , led by @erin_barreto
Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients.
Endorsed by @SIDPharm @IDSAInfo @ESCMID -EPASG @ACCP @SCCM @IATDMCT #idxposts
accpjournals.onlinelibrary.w…
Fra Ian 🇪🇺 retweeted
#KDOQI US Commentary on the @goKDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis
bit.ly/KDOQI26Lupus (FREE)
@SaynaNorouzi @NKF_NephPros
Fra Ian 🇪🇺 retweeted
Maintenance #Rituximab improve long term outcomes in idiopathic nephrotic sd: lower relapse risk, better remission, reduced proteinuria & steroid-sparing effect, without increased infections.
This supports maintenance 6–12 months after 1st infusion. @AfricanAFRAN @ISNkidneycare
Fra Ian 🇪🇺 retweeted
Bayes' Theorem is a fundamental concept in data science.
But it took me 2 years to understand its importance.
In 2 minutes, I'll share my best findings over the last 2 years exploring Bayesian Statistics. Let's go.
Fra Ian 🇪🇺 retweeted
Understanding P-Values is essential for improving regression models.
In 2 minutes, I'll crush your confusion.
Let's go:
Fra Ian 🇪🇺 retweeted
How do weight loss drugs compare? Here are the results of a recent network meta-analysis 💡
📸: BMJ 2026
Fra Ian 🇪🇺 retweeted
The effect of icodextrin on peritoneal dialysis patients with congestive heart failure: a time-varying exposure design and target trial emulation approach
doi.org/10.1093/ndt/gfaf265
Fra Ian 🇪🇺 retweeted
B cell maturation, treatment targets, and therapies ca. 2026 from @Kidney_Int @goKDIGO
#Nephpearls
👉 pubmed.ncbi.nlm.nih.gov/4203… – at Riverside, IL
Fra Ian 🇪🇺 retweeted
Prevalence of anti-rituximab antibodies in autoimmune forms of glomerulonephritis and podocytopathies
🔓doi.org/10.1093/ndt/gfag137
Fra Ian 🇪🇺 retweeted
How high is high 🤔and how to effectively lower anti-PLA2Rs 💊? Thanks for presenting all these twists and turns ✨@NephRodby @TWhittier_RUSH @Proximal_Baxi @Rush_Nephrology @BajinderR @n0r0zha @s_almutar @rahaai
Fra Ian 🇪🇺 retweeted
Pathophysiology of pregnancy-associated acute kidney injury
doi.org/10.1093/ndt/gfag142






















































